B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature.

Authors :: Arribas I
Maluquer C
Pomares H
Carro I
Baca C
Bosch A
Arévalo CE
Montané C
Ribes-Amorós J
Zamora L
Granada I
Gamundi E
Arnan M
Sureda A
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2023 Oct; Vol. 64 (10), pp. 1701-1705. Date of Electronic Publication: 2023 Jul 17.
Publication Year :: 2023

Subjects :: Humans
Lenalidomide adverse effects
Thalidomide adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Full Text Access

Tools